Search results for "mRNA integrity variation"

Transcript renin-angiotensin system, ACE2 receptor binding, AT1R overactivation, spike protein effects, mRNA Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Mechanistic critique of mRNA Regarding mRNA vaccine technology, Dr. Sabatier expressed concerns about lipid nanoparticle biodistribution, pseudouridine-modified mRNA stability

Witness Testimony Keywords from Transcript mRNA quantity claims, DNA contamination allegation, lipid and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Allegations that COVID-19 mRNA Shoemaker, an Ontario physician with more than four decades of clinical experience, testified that COVID-19 mRNA He asserted that each injection delivers tens of trillions of mRNA strands, along with DNA contamination

Reduction, All-Cause Hospitalization, Risk Ratio, Confidence Interval, Vaccine Efficacy Decline, Omicron Variant and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Harm–Benefit Analysis of mRNA specializing in harm–benefit analysis, testified regarding his published reanalysis of the Pfizer and Moderna mRNA He stated that waning efficacy, high rates of prior infection, and variant changes complicate harm–benefit

hydroxychloroquine treatment, lockdown policies, PCR testing cycles, excess mortality, vaccine adverse events, mRNA DNA integration concern, fertility decline, turbo cancers claim, WHO governance, GAVI funding influence He raised concerns about potential genomic integration of mRNA, excess mortality trends following vaccination

Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Neuropathological concerns regarding mRNA about spike protein neurotoxicity, biodistribution, and potential long-term neurological effects of mRNA the University of British Columbia, testified regarding potential neurological risks associated with mRNA

Mechanistic critique of mRNA COVID-19 vaccines based on spike protein interaction with the renin-angiotensin Biochemical critique of mRNA COVID-19 vaccine quality control, spike protein variability, biodistribution , genomic integration potential, and implications for immune response and public policy. 12, 2023 Quebec City Day Two: Full Day Testimony Regulatory classification and safety evaluation of mRNA including efficacy endpoints, statistical bias, antibody measurement timing, regulatory oversight, and data integrity

6.4.1 DNA / RNA Contamination and Long-Term Health Risks 6.4 Health 6.4.1 DNA / RNA Contamination and These findings call for immediate action to: Immediately Discontinue Use of mRNA vaccines. Studies: Assess the long-term health impacts of the vaccines—particularly concerning cancer and genetic integration

testimonies and findings from the NCI Report underscore the need for: Immediately Discontinuing Use of mRNA Long-term effects of novel drugs must be considered, and ethical considerations should be integrated

Witness Testimony Keywords from Transcript RNA microRNA research, lipid nanoparticle expertise, CT cycle Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Scientific critique of mRNA vaccine side effects, opposition to child vaccination, suspensions for public statements, and argues that mRNA Patrick Provost, a full professor and RNA researcher at Université Laval, testified regarding his scientific He argued that mRNA vaccines function as pro-drugs with unpredictable biodistribution and spike protein

findings from the 2023 NCI Report underscore the urgent need for: Immediately Discontinuing Use of mRNA Encouraging open debate and whistleblowing is essential for maintaining the integrity of public health

Keywords from Transcript PCR cycle thresholds, false positives, lockdown harms, contact tracing failure, mRNA Main Topic Scientific and personal testimony criticizing pandemic policies, PCR testing practices, mRNA She also questioned assumptions communicated to the public about mRNA vaccine distribution in the body

November 2023 Main Topic Testimony alleging unprecedented safety signals in VAERS following COVID-19 mRNA Jessica Rose testified that the COVID-19 mRNA products were rushed through truncated clinical trials Rose concluded that while definitive genomic integration evidence is not yet established, the theoretical